Atlas Trials

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Clinical trial NCT02682927 · COMPLETED

Trial details

NCT number
NCT02682927
Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dravet SyndromeSeizure Disorder
Start date
2016-01-15
Primary completion
2020-07-29
Enrollment
262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.